PIRRO, Elisa
 Distribuzione geografica
Continente #
NA - Nord America 2.870
EU - Europa 1.728
AS - Asia 529
SA - Sud America 29
OC - Oceania 16
AF - Africa 12
Continente sconosciuto - Info sul continente non disponibili 1
Totale 5.185
Nazione #
US - Stati Uniti d'America 2.857
IT - Italia 400
CN - Cina 284
DK - Danimarca 239
IE - Irlanda 186
SE - Svezia 177
FR - Francia 144
DE - Germania 112
UA - Ucraina 97
FI - Finlandia 85
AT - Austria 59
GB - Regno Unito 57
KR - Corea 56
JP - Giappone 54
IN - India 48
PL - Polonia 42
BE - Belgio 40
ES - Italia 33
VN - Vietnam 23
BR - Brasile 17
AU - Australia 15
TR - Turchia 14
SG - Singapore 9
CA - Canada 8
CH - Svizzera 8
GR - Grecia 8
NL - Olanda 7
JO - Giordania 6
RO - Romania 6
IR - Iran 5
PK - Pakistan 5
PT - Portogallo 5
RS - Serbia 5
RU - Federazione Russa 5
SN - Senegal 5
TW - Taiwan 5
CL - Cile 4
ID - Indonesia 4
MX - Messico 4
BG - Bulgaria 3
CZ - Repubblica Ceca 3
DZ - Algeria 3
EC - Ecuador 3
EG - Egitto 3
MK - Macedonia 3
MY - Malesia 3
TH - Thailandia 3
UZ - Uzbekistan 3
AR - Argentina 2
HK - Hong Kong 2
AF - Afghanistan, Repubblica islamica di 1
BT - Bhutan 1
CO - Colombia 1
CY - Cipro 1
EU - Europa 1
HR - Croazia 1
IL - Israele 1
LV - Lettonia 1
ME - Montenegro 1
NZ - Nuova Zelanda 1
PE - Perù 1
PR - Porto Rico 1
SA - Arabia Saudita 1
SI - Slovenia 1
TN - Tunisia 1
UY - Uruguay 1
Totale 5.185
Città #
Ann Arbor 530
Chandler 450
Houston 196
Dublin 176
Beijing 172
Fairfield 131
Torino 105
Ashburn 99
Villeurbanne 96
Nyköping 81
Dearborn 78
Wilmington 74
Jacksonville 71
Woodbridge 67
Princeton 63
Vienna 58
Medford 55
Redwood City 50
Cambridge 49
Seattle 45
Turin 36
Brussels 34
Fremont 32
Warsaw 31
Pisa 28
New York 27
Boston 24
Milan 24
Dong Ket 16
Boardman 15
Hefei 13
Nanjing 13
Florence 12
San Diego 12
Shanghai 12
Tokyo 11
Guangzhou 10
London 10
Cork 8
Paris 8
Düsseldorf 7
Shenzhen 7
Valencia 7
Würzburg 7
Cuneo 6
Jinan 6
Kunming 6
Nanchang 6
Piemonte 6
São Paulo 6
Bangalore 5
Belgrade 5
Fürstenzell 5
Helsinki 5
Madrid 5
Mumbai 5
Norwalk 5
Phoenix 5
Rome 5
Taipei 5
Toronto 5
Verona 5
Washington 5
Zurich 5
Esslingen am Neckar 4
Falls Church 4
Istanbul 4
Komancza 4
Kumar 4
Nottingham 4
Philadelphia 4
Pune 4
Siena 4
Tianjin 4
Amman 3
Anghiari 3
Bari 3
Bobrowniki Male 3
Boulder 3
Cardenal 3
Copenhagen 3
Dallas 3
Elche 3
Fuzhou 3
Grafing 3
Hamamatsu 3
Heidelberg 3
Islamabad 3
Kharkiv 3
Konya 3
Lebanon 3
Los Angeles 3
Portici 3
Quattro Castella 3
Saint-Anselme 3
Santiago 3
Silver Spring 3
Stuttgart 3
Sydney 3
Tarragona 3
Totale 3.274
Nome #
Influence of the CYP2B6 polymorphism on the pharmacokinetics of mitotane. 404
A new HPLC-UV validated method for therapeutic drug monitoring of tyrosine kinase inhibitors in leukemic patients. 383
Pharmacokinetic evaluation of oral itraconazole for antifungal prophylaxis in children 363
A new HPLC UV validated method for therapeutic monitoring of deferasirox in thalassaemic patients. 182
Deferasirox pharmacokinetic and toxicity correlation in β-thalassaemia major treatment 180
Deferasirox pharmacokinetics evaluation in a woman with hereditary haemochromatosis and heterozygous β-thalassaemia 159
Genetic determinants of mitotane pharmacokinetics in adrenocortical cancer patients 152
New hplc-mass spectrometry method for the simultaneous quantification in human plasma of the antileukemia drugs imatinib, dasatinib, and nilotinib 149
Plasma and Intracellular Imatinib Concentrations in Patients With Chronic Myeloid Leukemia 147
Role of Cytochrome P450 in imatinib pharmacokinetics: clinical relevance of inhibitors/inducers concomitant use 139
Procedimento cromatografico di dosaggio di DDT, DDD, DDA, e DDE 137
EVALUATION OF NAUSEA AND VOMITING IN ONCOLOGY PATIENTS TREATED WITH CHEMOTHERAPY: A RETROSPECTIVE STUDY 137
Pharmacogenetic determinants of mitotane pharmacokinetics in adrenocortical cancer patients 135
A new simple HPLC method for measuring mitotane and its two principal metabolites Tests in animals and mitotane-treated patients 130
Role of cytochrome P450 in imatinib pharmacokinetics: clinical relevance of inhibitors/inducers concomitant use 129
Evaluation of Posaconazole Pharmacokinetics in Adult Patients with Invasive Fungal Infection 129
Preclinical pharmacokinetics comparison between resveratrol 2-hydroxypropyl-β-cyclodextrin complex and resveratrol suspension after oral administration 124
Short QT syndrome in infancy. Therapeutic drug monitoring of hydroquinidine in a newborn infant. 121
Effect of pharmacogenetic markers of vitamin D pathway on deferasirox pharmacokinetics in children 120
Bioequivalence of Branded and Generic Oxaliplatin: From Preclinical Assessment to Clinical Incidence of Hypersensitivity Reactions 107
Circannual variation of mitotane and its metabolites plasma levels in patients with adrenocortical carcinoma 96
Therapeutic drug monitoring of voriconazole for treatment and prophylaxis of invasive fungal infection in children 93
Role of CYP24A1, VDR and GC gene polymorphisms on deferasirox pharmacokinetics and clinical outcomes 92
Clinical relevance of the assessment of deferasirox trough levels in thalassemia patients 89
Deferasirox pharmacokinetic evaluation in β-thalassaemia paediatric patients 88
Role of CYP1A1, ABCG2, CYP24A1 and VDR gene polymorphisms on the evaluation of cardiac iron overload in thalassaemia patients 76
New hplc–uv validated method for therapeutic drug monitoring of antifungal agents in acute myeloid leukemia 75
Clinical relevance of deferasirox trough levels in β-thalassemia patients 73
Genetic determinants of mitotane pharmacokinetics in adrenocortical cancer patients 71
Influence of the CYP2B6 polymorphism on the pharmacokinetics of mitotane. 71
Quantification of imatinib plasma levels in patients with chronic myeloid leukemia: Comparison between HPLC-UV and LC-MS/MS 69
Salicylic acid inhibits dimethylbenzanthracene (DMBA) induced mammary carcinogenesis in a dose dipendent manner 68
Antineoplastic effects of SU5416, a novel vascular endothelial growth factor pathway inhibitor, in an oral cancer model 67
Evaluating the impact of angiogenetic inhibitors on chemical carcinogenesis of oral tumors in the buccal pouch Syrian hamster model 66
EVALUTATION OF THE CONTROL OF PAIN IN PATIENTS WITH BONE METASTASIS UNDERGOING MEDICAL TREATMENT WITH BISPHOSPHONATES 66
New HPLC-MS method for the simultaneous quantification of the antileukemia drugs imatinib, dasatinib, and nilotinib in human plasma 65
The effect of vitamin D pathway genes and deferasirox pharmacogenetics on liver iron in thalassaemia major patients 65
Influence of single nucleotide polymorphisms on deferasirox Ctrough levels and effectiveness: study on beta-talassemia major affected patients 63
Determinanti farmacogenetici della farmacocinetica del mitotane: studio condotto su pazienti affetti da carcinoma corticosurrenalico 61
Pharmacogenetic of voriconazole antifungal agent in pediatric patients 60
Genetic determinants of mitotane pharmacokinetics in adrenocortical cancer patients 59
Single nucleotide polymorphisms of ABCB1 gene influence on intracellular concentrations of dasatinib. 52
Salicylate inhibition of rat mammary carcinogenesis and angiogenesis in female rat compatible with misoprostol administration 50
Pharmacogenetic determinants of mitotane pharmacokinetics in adrenocortical cancer patients 48
Pharmacogenetic determinants of mitotane pharmacokinetics in adrenocortical cancer patients 46
Salicylate counteracts streptozotocin induced diabetes mellitus in rat 43
Pharmacogenetic determinants of imatinib, dasatinib and nilotinib pharmacokinetics in chronic myeloid leukaemia patients 40
New HPLC MS method for the simultaneous quantification in human plasma of the antileukemia drugs imatinib, dasatinib and nilotinib. 40
Pharmacogenetic determinants of imatinib, dasatinib and nilotinib in chronic myeloid leukaemia patients 33
Role of CYP24A1, VDR and GC gene polymorphisms on deferasirox pharmacokinetics and clinical outcomes 19
VALIDATED MICROBIOLOGICAL ASSAY FOR JOSAMYCIN DETERMINATION IN ITS PHARMACEUTICAL FORMULATIONS 6
Totale 5.437
Categoria #
all - tutte 12.501
article - articoli 0
book - libri 0
conference - conferenze 4.583
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 17.084


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019267 0 0 0 0 0 0 0 44 18 66 89 50
2019/2020980 29 27 35 79 82 230 99 49 69 103 78 100
2020/2021616 86 41 35 39 53 49 32 23 74 35 70 79
2021/20221.026 69 65 69 84 53 90 95 65 42 47 198 149
2022/20231.167 119 125 67 126 86 257 64 81 119 30 68 25
2023/2024271 50 65 27 17 31 47 8 26 0 0 0 0
Totale 5.437